Streetbeat News

Products Services

ATHA

Athira Pharma presented new preclinical data at AAIC 2024 showing that its drug Fosgonimeton protects neurons from Alzheimer's disease-related pathology. The data demonstrated that Fosgonimeton mitigates amyloid-β-induced toxicity, lowers pTau levels, and reduces disruption of protein clearance mechanisms. The treatment also showed protective effects when used alone and in combination with lecanemab.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:28 pm

MGNX

MHUA

VST

Market-Moving News for July 31st: Meihua International's NT-2000 system supported a 5G remote robot-assisted lobectomy, boosting shares by 121%. MacroGenics shares fell 28% after announcing clinical data presentation and multiple analyst downgrades. Vistra shares rose 17% following the extension approval for Comanche Peak Nuclear Power Plant.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:28 pm

CTV

Innovid has launched Harmony Frequency, a new holistic frequency management solution aimed at reducing ad waste, strengthening campaign effectiveness, and improving the viewing experience across media portfolios for CTV and digital advertising.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:27 pm

ARDX

Ardelyx, Inc. (NASDAQ: ARDX) announced the publication of plain language summaries from two clinical trials on XPHOZAH® (tenapanor) in Current Medical Research and Opinion. These summaries aim to help patients with chronic kidney disease on dialysis understand the safety and efficacy of XPHOZAH, a phosphate absorption inhibitor approved by the FDA.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:27 pm

TOVX

Theriva Biologics announced that the FDA has granted Rare Pediatric Drug Designation for its VCN-01 to treat retinoblastoma. The lead product candidate also holds Orphan Drug Designation.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:27 pm

PWUP

Aspire Biopharma and PowerUp Acquisition Corp. have signed a non-binding letter of intent for a potential business combination. The combined public company would be listed on a national securities exchange.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:24 pm

MDAI

Spectral AI, Inc. (NASDAQ:MDAI) announced progress in developing the DeepView SnapShot M, a handheld AI-driven diagnostic tool for battlefield burn assessment.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:23 pm

ALBT

Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC, in which Avalon holds a 40% equity interest, has launched a direct-to-consumer DNA test for predisposition to opioid addiction.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:21 pm

DD

DuPont De Nemours, Inc. (NYSE: DD) reported better-than-expected Q2 earnings, with a 2% Y/Y sales increase to $3.171 billion and a 14% Y/Y rise in adjusted EPS to $0.97. The company raised its 2024 outlook and announced plans to split into three publicly traded entities, focusing on Electronics and Water businesses. DD shares rose 4.50% premarket.

Portfolio Pulse from Lekha Gupta

July 31, 2024 | 12:20 pm

INT

JBLU

JetBlue has signed an agreement with World Fuel Services to supply blended Sustainable Aviation Fuel (SAF) at JFK Airport starting Q4 2024. The initial 12-month deal includes a minimum of 1 million gallons of neat SAF, with an option for up to 4 million additional gallons. JetBlue is also inviting New York businesses to help scale the SAF market.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:19 pm